Financial comparisons Haisco Pharmaceutical Group Co., Ltd.
Equities
002653
CNE100001BC7
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.06 CNY | +2.08% |
|
+10.62% | +47.55% |
| Jul. 16 | Haisco Pharmaceutical Receives US FDA Approval for Autoimmune Drug Trials | MT |
| Jul. 07 | Haisco Pharmaceutical to Raise 1.37 Billion Yuan via Share Placement; Shares Slump 5% | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 510M | 10.63% | 13.64% | 9.42% | 5.88% | - | ||
| 45.04B | 23.51% | 31.78% | 84.84% | 14.84% | 1.88x | ||
| 88.82B | 15.84% | 29.8% | 34.23% | 13.95% | 0.36x | ||
| 56.33B | 7.59% | 41.43% | 263.08% | 13.34% | 2.56x | ||
| 40.31B | 34.78% | 44.19% | 80.78% | 25.88% | 0.52x | ||
| 66.76B | 13.68% | 34.42% | 43.45% | 15.69% | 0.74x | ||
| 50.32B | 23.73% | 38.74% | 34.74% | 15.58% | 0.85x | ||
| 54.07B | 13.01% | 31.31% | 32.11% | 12.51% | 1.47x | ||
| 64.17B | 26.68% | 36.46% | 46.35% | 17.38% | 0.86x | ||
| 33.42B | 12.24% | 44.96% | 177.29% | 11.36% | 2.33x | ||
| 63.63B | 12.62% | 34.24% | 19.99% | 8.05% | 1.52x | ||
| 28.75B | 1.67% | 29.63% | 27.6% | 9.57% | 1.48x | ||
| 11.02B | -4.86% | 6.31% | 0.65% | 0.49% | -6.77x | ||
| 42.53B | 13.98% | 27.61% | 11.75% | 4.43% | 0.68x | ||
| 48.3B | -18.53% | 10.77% | 10.23% | -9.53% | 6.49x | ||
| 7.45B | 33.09% | 46.3% | 22% | 18.71% | -1.74x | ||
| 39.28B | 8.21% | 29.16% | 48.09% | 10.97% | 1.22x | ||
| 3.83B | 22.64% | 26.77% | 14.73% | 13.49% | -2.98x | ||
| 30.6B | 2.36% | 7.48% | 1.5% | 1.19% | 3.6x | ||
| Average | 40.8B | 13.31% | 29.74% | 50.67% | 10.73% | 0.84x | |
| Weighted average by Cap. | 50.61B | 16.49% | 33.19% | 72.13% | 13.32% | 1.09x |
- Stock Market
- Equities
- 002653 Stock
- Sector Haisco Pharmaceutical Group Co., Ltd.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
